11.7 Toxidromes, Psychiatric Emergencies & Suicide Risk Assessment

1. Acute Psychiatric Toxic Emergencies: Serotonin Syndrome & NMS

1. Serotonin Syndrome (Serotonin Toxicity)

• Pathophysiology: Excessive stimulation of central and peripheral 5-HT 1A and 5-HT 2A receptors.
• Culprit Drug Combinations: SSRIs, SNRIs, MAOIs, TCAs, Tramadol, Meperidine, Methadone, Dextromethorphan, Linezolid (oxazolidinone antibiotic with intrinsic MAOI activity), Methylene Blue, MDMA (Ecstasy), Triptans, and St. John's Wort.
• Hunter Serotonin Toxicity Criteria (Gold Standard): In the presence of a serotonergic agent, diagnosis requires at least one of the following:
  1. Spontaneous clonus
  2. Inducible clonus PLUS agitation or diaphoresis
  3. Ocular clonus (slow, continuous, horizontal roving eye movements) PLUS agitation or diaphoresis
  4. Tremor PLUS Hyperreflexia
  5. Hypertonia PLUS Temperature > 38.0°C PLUS ocular or inducible clonus
• Clinical Manifestations: Acute onset (<24 hours); triad of:
  • Neuromuscular Excitation: Marked lower-extremity hyperreflexia (3-4+), spontaneous/inducible/ocular clonus, tremor, shivering, bilateral Babinski signs.
  • Autonomic Hyperactivity: Hyperthermia, profuse diaphoresis, facial flushing, tachycardia, labile hypertension, mydriasis, hyperactive bowel sounds with watery diarrhea.
  • Altered Mental Status: Severe agitation, restlessness, akathisia, delirium, confusion.
• Emergency Management:
  1. Immediately discontinue all serotonergic pharmacotherapies.
  2. Aggressive supportive care: IV crystalloids, continuous cardiac monitoring.
  3. IV Benzodiazepines (Diazepam 5-10 mg or Lorazepam 2-4 mg): Essential first-line therapy to control psychomotor agitation, blunt autonomic surge, and reduce muscle-generated hyperthermia.
  4. Specific Antidote (Cyproheptadine): First-generation 5-HT 2A antagonist; administer oral/NG initial dose of 12 mg, followed by 2 mg every 2 hours if symptoms persist, then maintenance 8 mg every 6 hours.
  5. Severe Hyperthermia (Temp >41.1°C / 106°F): Emergency endotracheal intubation, neuromuscular paralysis with non-depolarizing agents (Vecuronium; avoid Succinylcholine due to hyperkalemia and rhabdomyolysis risk), and ICU admission.

2. Neuroleptic Malignant Syndrome (NMS)

• Pathophysiology: Acute, profound blockade of central Dopamine D2 receptors in the corpus striatum (causing rigidity) and hypothalamus (causing hyperthermia), or abrupt withdrawal of dopaminergic agonists (e.g., Levodopa, Bromocriptine) in Parkinson's disease.
• Culprit Agents: High-potency typical antipsychotics (Haloperidol, Fluphenazine), low-potency (Chlorpromazine), atypical antipsychotics (Risperidone, Olanzapine, Quetiapine), and antiemetics (Metoclopramide, Prochlorperazine, Promethazine).
• Diagnostic Clinical Tetrad:
  1. Hyperthermia: Temperature typically > 38.0°C to 40.5°C (100.4°F to 105°F).
  2. Severe Muscle Rigidity: Generalized "Lead-pipe" rigidity across all muscle groups, accompanied by hyporeflexia and bradykinesia (distinguishes NMS from the hyperreflexia and clonus of Serotonin Syndrome).
  3. Altered Mental Status: Encephalopathy, mutism, stupor, catatonia, fluctuating delirium, coma.
  4. Autonomic Instability: Tachycardia, labile blood pressure, tachypnea, profuse diaphoresis, pallor, sialorrhea (drooling).
• Laboratory Hallmark: Markedly elevated Serum Creatine Kinase (CK > 1,000 to >100,000 IU/L), profound leukocytosis (WBC 10,000-40,000/mcL), elevated transaminases, metabolic lactic acidosis, and myoglobinuria leading to acute tubular necrosis / acute kidney injury.
• Emergency Management:
  1. Immediately discontinue all antipsychotics / neuroleptic agents (or immediately restart dopamine agonists if precipitated by Parkinson medication withdrawal).
  2. Emergent transfer to the Intensive Care Unit (ICU).
  3. Aggressive IV crystalloid hydration (target urine output >2 mL/kg/h) with urine alkalinization to prevent myoglobinuric acute renal failure.
  4. Active external cooling blankets and ice packs.
  5. IV Benzodiazepines (Lorazepam 1-2 mg IV q4-6h): Reduces rigidity and controls autonomic instability.
  6. Specific Pharmacologic Antidotes:
     • Dantrolene Sodium: Direct-acting skeletal muscle relaxant; blocks ryanodine receptors on the sarcoplasmic reticulum, inhibiting calcium release. Dose: 1 to 2.5 mg/kg IV bolus, repeated up to a maximum of 10 mg/kg/day; taper to oral after clinical improvement.
     • Bromocriptine Mesylate: Central dopamine D2 receptor agonist. Dose: 2.5 to 5 mg PO/NG TID, titrated up to 15-45 mg/day.
     • Amantadine: Dopaminergic and NMDA antagonist. Dose: 100 mg PO BID, titrated to 200 mg BID.

2. Comprehensive Suicide Risk Assessment & Clinical Safety Management

Suicide is a major public health crisis and a leading cause of premature mortality. Every primary care and hospital physician must conduct structured suicide risk evaluations.

Static vs. Dynamic Suicide Risk Factors

Suicide Risk Factor Stratification Matrix
===================================================================================
STATIC (NON-MODIFIABLE) RISK FACTORS:
- PRIOR SUICIDE ATTEMPT: The single strongest clinical predictor of completed suicide.
- Family History: Completed suicide in a first-degree relative.
- Demographics: Male sex (completes suicide 3-4x more often than females due to lethal methods);
  Older age (men >=65 years have highest demographic rate); Caucasian or Native American.
- Chronic Medical Illness: Terminal cancer, chronic intractable pain, severe neurological disease.
- Childhood Trauma: History of severe physical, emotional, or sexual abuse.

DYNAMIC (MODIFIABLE & ACUTE) RISK FACTORS:
- ACTIVE SUICIDAL INTENT & SPECIFIC PLAN: Defined method, timing, and preparation.
- ACCESS TO LETHAL MEANS: Firearms in the home, stockpiles of lethal medications.
- Severe Hopelessness & Despair: Strongest cognitive predictor of imminent suicidal behavior.
- Acute Intoxication / Active Substance Abuse: Impairs impulse control and judgment.
- Acute Psychosis: Command auditory hallucinations instructing self-harm.
- Severe Agitation, Psychomotor Restlessness, & Severe Intractable Insomnia.
- Acute Precipitating Crisis: Major interpersonal loss, divorce, financial ruin, legal crisis.
- Lack of Social Support / Social Isolation.
===================================================================================

Clinical Management & Lethal Means Restriction

1. Lethal Means Restriction (Critical Board Intervention):
   • Firearms: The presence of a firearm in the home increases the risk of suicide by 3 to 5-fold for all household members. Physicians must explicitly ask every suicidal patient about firearms in the home and counsel family members to safely lock, remove, or transfer firearms to law enforcement or trusted relatives outside the home.
   • Medications: Securely lock all household medications; prescribe only small, non-lethal quantities (e.g., 7-day supplies) with blister packaging; immediately dispose of unused opioids, sedatives, and TCAs.
2. Evidence-Based Safety Planning Intervention (SPI):
   • A collaborative, written, 6-step personalized safety plan identifying: (1) Personal warning signs of impending crisis, (2) Internal coping strategies (exercise, mindfulness), (3) Social distractions and social contacts, (4) Family members/friends who can help in crisis, (5) Professional mental health contacts and emergency services, and (6) Lethal means restriction steps.
   • Provide the National Suicide & Crisis Lifeline (Dial 988) and local crisis center numbers.
3. Triage & Disposition Decision Algorithm:
   • High Imminent Risk: Active suicidal ideation with specific intent, lethal plan, accessible lethal means, severe agitation/psychosis, or refusal to collaborate with safety plan.
     • Action: Mandates immediate inpatient psychiatric hospital admission.
     • Voluntary vs. Involuntary Admission: Always attempt voluntary hospitalization first. If the patient refuses and insists on leaving, the physician has an absolute legal and ethical duty to initiate an Emergency Involuntary Psychiatric Hold / Detention to secure patient safety. The patient must NEVER be left unattended.
   • Moderate / Low Risk: Passive suicidal ideation without intent or plan, strong social support, intact impulse control, future-oriented mindset, and reliable collaboration with safety plan.
     • Action: Safe for outpatient management with urgent (within 24-48 hours) psychiatric follow-up, lethal means removal verified with family, and 24/7 crisis numbers provided.